7LWC
| Goat beta-lactoglobulin mutant Q59A | 分子名称: | Beta-lactoglobulin | 著者 | Munoz, D.A, Dobson, R.C.J. | 登録日 | 2021-02-28 | 公開日 | 2021-04-21 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (3 Å) | 主引用文献 | Engineering food proteins for improved digestibility and lower allergenicity: a case study using caprine beta-lactoglobulin To Be Published
|
|
5HTD
| Recombinant bovine beta-lactoglobulin variant L1A/I2S with endogenous ligand (sBlgB#1) | 分子名称: | Beta-lactoglobulin, MYRISTIC ACID | 著者 | Loch, J.I, Bonarek, P, Tworzydlo, M, Polit, A, Hawro, B, Lach, A, Ludwin, E, Lewinski, K. | 登録日 | 2016-01-26 | 公開日 | 2016-07-20 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | Engineered beta-Lactoglobulin Produced in E. coli: Purification, Biophysical and Structural Characterisation. Mol Biotechnol., 58, 2016
|
|
6XVS
| Human myelin protein P2 mutant P38G, unliganded | 分子名称: | GLYCEROL, Myelin P2 protein | 著者 | Ruskamo, S, Lehtimaki, M, Kursula, P. | 登録日 | 2020-01-22 | 公開日 | 2020-04-08 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
|
|
5HTE
| Recombinant bovine beta-lactoglobulin variant L1A/I2S (sBlgB#2) | 分子名称: | Beta-lactoglobulin | 著者 | Loch, J.I, Bonarek, P, Tworzydlo, M, Polit, A, Hawro, B, Lach, A, Ludwin, E, Lewinski, K. | 登録日 | 2016-01-26 | 公開日 | 2016-07-20 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Engineered beta-Lactoglobulin Produced in E. coli: Purification, Biophysical and Structural Characterisation. Mol Biotechnol., 58, 2016
|
|
5HZ6
| |
7OXW
| CrabP2 mutant R30DK31D | 分子名称: | ACETATE ION, Cellular retinoic acid-binding protein 2, SULFATE ION | 著者 | Pastok, M.W, Basle, A, Endicott, J.A. | 登録日 | 2021-06-23 | 公開日 | 2022-07-13 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.16 Å) | 主引用文献 | Structural requirements for the specific binding of CRABP2 to cyclin D3 To Be Published
|
|
7OXX
| CrabP2 mutant R30AK31A | 分子名称: | Cellular retinoic acid-binding protein 2, SODIUM ION | 著者 | Tomlinson, C.W.E, Basle, A, Pohl, E. | 登録日 | 2021-06-23 | 公開日 | 2022-07-13 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.33 Å) | 主引用文献 | Structural requirements for the specific binding of CRABP2 to cyclin D3 To Be Published
|
|
6XUW
| Human myelin protein P2 mutant L27D | 分子名称: | CHLORIDE ION, Myelin P2 protein, PALMITIC ACID | 著者 | Ruskamo, S, Lehtimaki, M, Kursula, P. | 登録日 | 2020-01-21 | 公開日 | 2020-04-08 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2.31 Å) | 主引用文献 | Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
|
|
6XVQ
| Human myelin protein P2 mutant K31Q | 分子名称: | CITRIC ACID, Myelin P2 protein, PALMITIC ACID | 著者 | Ruskamo, S, Lehtimaki, M, Kursula, P. | 登録日 | 2020-01-22 | 公開日 | 2020-04-08 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
|
|
6XVY
| Human myelin protein P2 mutant R88Q | 分子名称: | CHLORIDE ION, CITRIC ACID, Myelin P2 protein, ... | 著者 | Ruskamo, S, Lehtimaki, M, Kursula, P. | 登録日 | 2020-01-22 | 公開日 | 2020-04-08 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
|
|
5HZ8
| FABP4_3 in complex with 6,8-Dichloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid | 分子名称: | 6,8-dichloro-4-phenyl-2-(piperidin-1-yl)quinoline-3-carboxylic acid, DIMETHYL SULFOXIDE, Fatty acid-binding protein, ... | 著者 | Ehler, A, Rudolph, M.G. | 登録日 | 2016-02-02 | 公開日 | 2016-12-14 | 最終更新日 | 2024-05-08 | 実験手法 | X-RAY DIFFRACTION (1.12 Å) | 主引用文献 | Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors. Bioorg. Med. Chem. Lett., 26, 2016
|
|
5HZ9
| |
6XU9
| Human myelin protein P2 mutant K3N | 分子名称: | CHLORIDE ION, CITRIC ACID, Myelin P2 protein, ... | 著者 | Ruskamo, S, Lehtimaki, M, Kursula, P. | 登録日 | 2020-01-17 | 公開日 | 2020-04-08 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
|
|
6XVE
| |
6XVR
| Human myelin protein P2 mutant L35S | 分子名称: | Myelin P2 protein, PALMITIC ACID, SULFATE ION | 著者 | Ruskamo, S, Lehtimaki, M, Kursula, P. | 登録日 | 2020-01-22 | 公開日 | 2020-04-08 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
|
|
5IO6
| |
7LSQ
| |
5IO7
| |
7Q18
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded form | 分子名称: | Beta-lactoglobulin, SULFATE ION | 著者 | Loch, J.I, Cymborowski, M.T, Minor, W, Lewinski, K. | 登録日 | 2021-10-18 | 公開日 | 2022-05-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.804 Å) | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7Q2N
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM) | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | 著者 | Loch, J.I, Barciszewski, J, Lewinski, K. | 登録日 | 2021-10-25 | 公開日 | 2022-05-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7Q2O
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1) | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | 著者 | Loch, J.I, Barciszewski, J, Lewinski, K. | 登録日 | 2021-10-25 | 公開日 | 2022-05-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7Q17
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded form | 分子名称: | 1,2-ETHANEDIOL, Beta-lactoglobulin | 著者 | Loch, J.I, Barciszewski, J, Lewinski, K. | 登録日 | 2021-10-18 | 公開日 | 2022-05-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7Q19
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3) | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | 著者 | Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. | 登録日 | 2021-10-18 | 公開日 | 2022-05-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.55 Å) | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7Q2P
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2) | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | 著者 | Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. | 登録日 | 2021-10-25 | 公開日 | 2022-05-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.69 Å) | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
5IO5
| |